Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine | NCT05718037 | Wuhan BravoVax Co., Ltd. | user2@example.com | None | 2023-08-01 | 2024-07-31 | 2025-07-31 | - | - | 2025-07-14 |
| Phase I Clinical Trial of a Candidate HPV Vaccine | NCT05672966 | Wuhan BravoVax Co., Ltd. | user2@example.com | None | 2023-08-01 | 2024-10-31 | 2025-10-31 | - | - | 2025-07-14 |
| Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine | NCT05706324 | Wuhan BravoVax Co., Ltd. | user2@example.com | None | 2023-06-30 | 2024-07-31 | 2025-07-31 | - | - | 2025-07-14 |
| Phase I Clinical Trial of a Candidate PCV13 in Healthy People | NCT05602480 | Wuhan BravoVax Co., Ltd. | user2@example.com | None | 2022-11-01 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |